Navigation Links
Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague”
Date:1/14/2014

Rochester, NY (PRWEB) January 14, 2014

During the 1600’s through the 1800’s doctors contributed unknowingly to what is now known as “The Doctor’s Plague.” In this time period, doctors did not know that they needed to wash their hands. This led, at times, to the death of vulnerable patients. In the same way, medical interns and hospital staff today don’t know that they may be unwittingly transmitting herpes viruses to their patients. The CBCD explains.

A study showed that severe fatigue contributed to latent herpes virus reactivation in modern medical interns. The reactivated virus was then transmitted unknowingly to patients as medical interns made their rounds. The study was published on November 9, 2011 in the journal of Interdisciplinary Perspectives on Infectious Diseases (2).

Study authors wrote that “Chronic exposure to complex cognitive and noncognitive stressors (during medical residency) can progress to distress (and) leads to general fatigue (which) has been shown to alter immune responsiveness and (lead to) reactivation of the latent herpes viruses… (2).” In other words, medical interns are exposed to situations that cause extreme fatigue. This fatigue weakens the immune system, which in turn, reactivates the latent herpes virus.

“Physicians, especially those in training, typically work long hours and are often fatigued due to sleep deprivation; fatigue contributes to the human component of medical errors and, thus, jeopardizes patient safety. Decrease in cognitive function was observed among Ob/Gyn residents and medical students … (2).” Moreover, study authors wrote that in these medical interns, “We have detected reactivation of latent herpes viruses that suggests immune suppression (2).”

Reactivation of latent herpes viruses in medical interns places patients at risk. As the study notes, “Fatigue among residents and increased shedding of herpes virus DNA are the major findings of this study. Our subjects have daily close contact with patients in a tertiary care hospital and rotate between intensive care units, operating rooms, the emergency department, inpatient floors, and outpatient clinics. These patients often have a weakened immune system. Increased shedding of viruses by fatigue stressed residents contributes to an unfavorable epidemiological environment (2).”

The CBCD therefore recommends that doctors, medical interns, and hospital administrators learn about Gene-Eden-VIR, a natural product that was tested by scientists at the Center and was proven to reduce symptoms of a herpes infection.

“Control the latent virus and keep it from reactivating can help protect patients. We believe that medical interns and their supervisors owe it to themselves, and to their patients, to become familiar with our research.” – Greg Bennett, CBCD

A clinical study, conducted by scientists at the Center for the Biology of Chronic Disease, and which followed the FDA guidelines for clinical studies, showed that the natural supplement, Gene-Eden-VIR safely and effectively decreases the feeling of fatigue in treated individuals. Specifically, the study found that the natural antiviral product decreased the feeling of general fatigue, the feeling of physical fatigue, and the feeling of mental fatigue (3). The abstract of the study was posted on the Center for the Biology of Chronic Disease website on December 28, 2013 ahead of publication.

To learn more about the CBCD’s research on fatigue, visit http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.

References:

(1)    WebMD - Common Symptoms of Genital Herpes. Last Reviewed on December 24, 2013.
http://www.webmd.com/genital-herpes/guide/common-symptoms?page=2

(2) Fatigue in medical residents leads to reactivation of herpes virus latency. Published on November 9, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/22229027

(3) Gene-Eden-VIR is Effective Against Fatigue: Results of a Post Marketing Clinical Study Conducted According to the FDA Guidelines. Page last updated on December 27, 2013.
        http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11483359.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study: Risk of Acquiring Genital Warts in the Mouth from Sex is 50%; polyDNA Recommends Targeting Latent HPV with Gene-Eden-VIR
2. Study: RSV often milder than flu in older adults
3. Study: Latent Viruses Change Cells in the Human Body; the Study Supports the Link between Latent Viruses and Disease
4. Study: Higher Hepatitis C Infection During Acupuncture in Asian Americans; polyDNA Recommends That Doctors Prescribe Gene-Eden-VIR against HCV
5. Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc.
6. Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.
7. Study: FOLFIRINOX Followed by Chemoradiation Shows Substantial Activity in Locally Advanced Pancreatic Cancer
8. New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy
9. Study: Brain Imaging After Mild Head Injury/Concussion Can Show Lesions
10. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
11. Nature Materials study: Boosting heat transfer with nanoglue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... MA (PRWEB) , ... January ... ... leader in Less Exposure Surgery (LES®) Technologies, announced today the next evolution ... PedFuse Pedicle Screw System platform). In contrast to the competition, SpineFrontier is ...
(Date:1/19/2017)... -- Market Research Future has a half cooked research report on Global ... rapidly and expected to reach USD 450 Million by the end ... ... been assessed as a swiftly growing market and expected that the ... future. There has been a tremendous growth in the prevalence of ...
(Date:1/19/2017)... 2017 /PRNewswire -- WuXi AppTec, a leading global ... technology platform, today announced that it has acquired ... drug discovery contract research organization (CRO). After completion ... subsidiary of WuXi, and will continue to focus ... services. The acquisition will further strengthen WuXi,s R&D ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... for pharmaceutical research and development (R&D), today announced the launch of ... and interpretation for the rapidly evolving field of precision medicine. , ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
(Date:1/3/2017)... VEGAS , Jan. 3, 2017 Onitor, ... the introduction of Onitor Track, an innovative biometric data-driven ... men, showcasing this month at the 2017 Consumer Electronics ... In the U.S., the World Health ... more than two-thirds of adults who are overweight or ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
Breaking Biology News(10 mins):